Get started
NOVARTIS AG CHF0.50 (2ND BUYBACK LINE)NOVARTIS AG CHF0.50 (2ND BUYBACK LINE)NOVARTIS AG CHF0.50 (2ND BUYBACK LINE)

NOVARTIS AG CHF0.50 (2ND BUYBACK LINE)

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals

0QM7 chart

Key stats

Market capitalization
‪188.07 B‬CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
11.7703
Basic EPS (TTM)
6.5739CHF
Net income (FY)
‪13.34 B‬CHF
Revenue (FY)
‪40.83 B‬CHF
Shares float
‪1.75 B‬
Beta (1Y)
0.72

About NOVARTIS N

Sector
Health Technology
CEO
Vasant Narasimhan
Headquarters
Basel
Website
novartis.com
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0038459415
FIGI
BBG00JYV5Q72
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where 0QM7 is featured.

See all sparks 

Frequently Asked Questions

The current price of 0QM7 is 76.8600 CHF — it hasn't changed in the past 24 hours. Watch NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) stocks are traded under the ticker 0QM7.
0QM7 reached its all-time high on May 15, 2018 with the price of 78.3600 CHF, and its all-time low was 75.0400 CHF and was reached on Apr 26, 2018. View more price dynamics on 0QM7 chart.
See other stocks reaching their highest and lowest prices.
0QM7 stock is 0% volatile and has beta coefficient of 0.72. Track NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) there?
Today NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) has the market capitalization of ‪185.77 B‬, it has decreased by 1.26% over the last week.
Yes, you can track NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) financials in yearly and quarterly reports right on TradingView.
0QM7 net income for the last quarter is ‪2.35 B‬ CHF, while the quarter before that showed ‪7.52 B‬ CHF of net income which accounts for −68.76% change. Track more NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) financial stats to get the full picture.
No, 0QM7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 9, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) EBITDA is ‪18.76 B‬ CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) financial statements.
Like other stocks, 0QM7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG CHF0.50 (2ND BUYBACK LINE) stock right from TradingView charts — choose your broker and connect to your account.